CVE-2015-3955 json
Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers t…
published 2015-07-06 11 y ago modified 2026-06-17 4 mo ago also EUVD-2015-3986
- cvss
- 10.0
- version 2.0, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 6.6%
- EPSS 6.6% chance of exploitation in 30 days, percentile 93%
- public exploits
- 0
- none known
Summary
Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to execute arbitrary code via unspecified vectors.
Vendor advisories
What the vendors themselves say about their products: affected, fixed or not affected, and what to do.
cisa ICSA-15-161-01 updated cvss 7.6
Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities
-
Hospira Plum A+ Infusion System <=13.4 Hospira Plum A+3 Infusion System <=13.6 Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. Accordi <=3.13affected: mitigation “For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.”
From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf
cisa ICSA-15-125-01B updated cvss 7.6
Hospira LifeCare PCA Infusion System Vulnerabilities
-
Hospira LifeCare PCA Infusion System <=5.0affected: mitigation “For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.”
From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf
Exploit prediction
6.62% chance of exploitation in the next 30 days, higher than 93% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| NVD | 2.0 | 10.0 | AV:N/AC:L/Au:N/C:C/I:C/A:C |
Classification
- Weakness
-
- CWE-119 Improper Restriction of Operations within the Bounds of a Memory Buffer
References
-
fda.gov
/MedicalDevices/Safety/AlertsandNotices/ucm446809.htm
third-party-advisory, us-government-resource
-
securityfocus.com
/bid/75132
vdb-entry
-
ics-cert.us-cert.gov
/advisories/ICSA-15-125-01B
third-party-advisory, us-government-resource
Sources
- CVE List CVE-2015-3955
- NVD CVE-2015-3955
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.